Literature DB >> 10686149

Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.

A K Patra1, R Mukhopadhyay, R Mukhija, A Krishnan, L C Garg, A K Panda.   

Abstract

Recombinant human growth hormone (r-hGH) was expressed in Escherichia coli as inclusion bodies. In 10 h of fed-batch fermentation, 1.6 g/L of r-hGH was produced at a cell concentration of 25 g dry cell weight/L. Inclusion bodies from the cells were isolated and purified to homogeneity. Various buffers with and without reducing agents were used to solubilize r-hGH from the inclusion bodies and the extent of solubility was compared with that of 8 M urea as well as 6 M Gdn-HCl. Hydrophobic interactions as well as ionic interactions were found to be the dominant forces responsible for the formation of r-hGH inclusion bodies during its high-level expression in E. coli. Complete solubilization of r-hGH inclusion bodies was observed in 100 mM Tris buffer at pH 12.5 containing 2 M urea. Solubilization of r-hGH inclusion bodies in the presence of low concentrations of urea helped in retaining the existing native-like secondary structures of r-hGH, thus improving the yield of bioactive protein during refolding. Solubilized r-hGH in Tris buffer containing 2 M urea was found to be less susceptible to aggregation during buffer exchange and thus was refolded by simple dilution. The r-hGH was purified by use of DEAE-Sepharose ion-exchange chromatography and the pure monomeric r-hGH was finally obtained by using size-exclusion chromatography. The overall yield of the purified monomeric r-hGH was approximately 50% of the initial inclusion body proteins and was found to be biologically active in promoting growth of rat Nb2 lymphoma cell lines. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686149     DOI: 10.1006/prep.1999.1179

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  53 in total

1.  High-throughput automated refolding screening of inclusion bodies.

Authors:  Renaud Vincentelli; Stéphane Canaan; Valérie Campanacci; Christel Valencia; Damien Maurin; Frédéric Frassinetti; Loréna Scappucini-Calvo; Yves Bourne; Christian Cambillau; Christophe Bignon
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

2.  Production and Purification of a Novel Anti-TNF-α Single Chain Fragment Variable Antibody.

Authors:  Ali Akbar Alizadeh; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-12-31

3.  Improved production of the recombinant phospholipase A1 from Polybia paulista wasp venom expressed in bacterial cells for use in routine diagnostics.

Authors:  Amilcar Perez-Riverol; Alexis Musacchio-Lasa; Luis Gustavo Romani Fernandes; Jose Roberto Aparecido Dos Santos-Pinto; Franciele Grego Esteves; Murilo Luiz Bazon; Ricardo de Lima Zollner; Mario Sergio Palma; Márcia Regina Brochetto-Braga
Journal:  3 Biotech       Date:  2020-04-27       Impact factor: 2.406

4.  Efficient solubilization, purification of recombinant extracellular alpha-amylase from pyrococcus furiosus expressed as inclusion bodies in Escherichia coli.

Authors:  Lisa Wang; Qinhua Zhou; Huayou Chen; Zhongmei Chu; Jianfeng Lu; Yi Zhang; Shengli Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2006-11-22       Impact factor: 3.346

5.  Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins.

Authors:  Eui Nam Lee; Young Mok Kim; Hye Ja Lee; Sang Woo Park; Han Young Jung; Jae Myun Lee; Yong-Ho Ahn; Jongsun Kim
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 6.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

7.  Production and characterization of a single-chain Fv antibody-alkaline phosphatase fusion protein specific for clenbuterol.

Authors:  Xixia Liu; Hong Wang; Yan Liang; Jinyi Yang; Hongbin Zhang; Hongtao Lei; Yudong Shen; Yuanming Sun
Journal:  Mol Biotechnol       Date:  2010-05       Impact factor: 2.695

8.  Cost-effective production of recombinant human interleukin 24 by lactose induction and a two-step denaturing and one-step refolding method.

Authors:  Muhammad Imran Amirzada; Minglei Yu; Xiaohai Gong; Yun Chen; Ruiyu Zhu; Jianyong Lei; Jian Jin
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-31       Impact factor: 3.346

9.  Purification of Chinese Sacbrood Virus (CSBV), Gene Cloning and Prokaryotic Expression of its Structural Protein VP1.

Authors:  Pengjie Wu; Huimin Yu; Jin Xu; Jiangli Wu; Awraris Getachew; Yangyang Tu; Zhanbao Guo; Hongyan Jin; Shufa Xu
Journal:  Mol Biotechnol       Date:  2018-12       Impact factor: 2.695

10.  Process for production and purification of Lethal Toxin Neutralizing Factor (LTNF) from E. coli and its economic analysis.

Authors:  Vishwanath Hebbi; P Kathiresan; Devendra Kumar; Claire Komives; Anurag S Rathore
Journal:  J Chem Technol Biotechnol       Date:  2017-12-05       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.